IASO Compilation-700x400

More Than Skin Deep: Dassault Systèmes is Transforming the Patient Experience

Dassault Systèmes 3DExperience North America 2019 Forum Event Brief

By: Daniel R. Matlis, President

At this year’s 3DEXPERIENCE North America Forum, Dassault Systèmes continued to demonstrate its commitment to transforming the patient experience.

Under the leadership of Bernard Charlès, Vice Chairman, Chief Executive Officer, the company continues to substantially deliver on the promise: “to enable innovative patient experiences through a Holistic Patient-Centric strategy.”  (Read:  Dassault Targets Life-Sciences with Mind, Body and Soul)

According to Charlès there are several concurrent themes that are impacting the Life Science industry with Bioscience playing a major role.

  • Healthcare is expensive
  • Healthcare needs to be more inclusive
  • Life-Science product development needs to take advantage of technological changes

“Dassault Systèmes is investing massively in Life Sciences to transform the patient experience with a culture of sustainable innovation and the use of cutting edge technology,” added Charles.

At the 3DExperience Forum, the company once again delivered on their vision with the introduction of IASO, an oncology treatment concept that contains a removable patch that attaches to the patient’s skin to deliver a biologic solution, dosed through a connected, wearable and reusable device.  IASO aims to showcase how Dassault Systèmes 3DEXPERIENCE platform enables its customers to transform the patient experience with innovative solutions that combine many technologies to safely shift the point of care from the clinic…to the patient’s home.

Presentations of Note

Erik Gatenholm, Co-Founder and CEO of CELLINK, wants to create the future of medicine by developing “novel technologies that allows researchers and scientists to create new human tissues and organs.”  His vision is to provide the technology that is also a cost effective solution to allow more researchers around the world to get access to 3D bioprinting.

Milind Rao, Ph.D., Staff Mechanical Engineer, Product Design Team, Dexcom, Inc. noted that computer simulations in healthcare have significantly evolved over time and is a critical part of medical device design and development. This presentation walked through various analytical methods that have been successfully used to build robust devices. Dexcom, Inc. is the leader in transforming diabetes care and management by providing continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes.

Download a PDF of the complete Event Brief

Bookmark and Share

Leave a Reply